Scientists shut down cancer DNA repair to overcome drug resistance
Cancer cells often survive treatment by fixing the DNA damage that therapy is meant to cause. Researchers found that UNI418 can disrupt this repair ability, leaving cancer cells more exposed. When combined with a PARP inhibitor, it helped resistant cancer cells respond to treatme
Cancer cells often survive treatment by fixing the DNA damage that therapy is meant to cause. Researchers found that UNI418 can disrupt this repair ability, leaving cancer cells more exposed. When combined with a PARP inhibitor, it helped resistant cancer cells respond to treatment again. The findings point to a new strategy for overcoming cancer drug resistance.
This report comes from ScienceDaily. The story centres on Scientists shut down cancer DNA repair to overcome drug resistance. Full coverage and background context is available at the original source. Readers seeking more detail on this developing topic are encouraged to follow updates from ScienceDaily and related outlets covering this beat.
